Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia
Clinical trial NCT06702098 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06702098
- Sponsor
- Guangzhou Ruixin Biotechnological Co., LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2026-08-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.